http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Kurokawa, Manabu,Kim, Jiyeon,Geradts, Joseph,Matsuura, Kenkyo,Liu, Liu,Ran, Xu,Xia, Wenle,Ribar, Thomas J.,Henao, Ricardo,Dewhirst, Mark W.,Kim, Wun-Jae,Lucas, Joseph E.,Wang, Shaomeng,Spector, Neil L AAAS 2013 Science signaling Vol.6 No.274
<P><B>Breaking Down to Build Resistance</B></P><P>Chemotherapeutic resistance often arises because of the rewiring of signaling pathways in cancer cells. Kurokawa <I>et al.</I> found that the ubiquitin E3 ligase MDM2 triggered the breakdown of another ubiquitin E3 ligase, HUWE1. In breast cancer cells that died when exposed to the HER2 (human epidermal growth factor receptor 2) EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor lapatinib, MDM2 was degraded, which enabled HUWE1 to trigger the degradation of a prosurvival protein and promote assembly and activation of a protein complex required for the execution of cell death. However, MDM2 degradation did not occur in lapatinib-resistant breast cancer cells, and thus, the abundance of HUWE1 was decreased, promoting cell survival. In a mouse xenograft model, an inhibitor of MDM2 reduced the growth of tumors generated from lapatinib-resistant breast cancer cells. Thus, MDM2 could be targeted to circumvent resistance to lapatinib in breast cancers.</P>